Upcoming CDER Meetings and Conferences

Receive this email as a forward? Subscribe to CDER SBIA industry updates. FDA | CDER | Small Business and Industry Assistance INDUSTRY NEWS . Upcoming CDER Meetings and Conferences Find details and additional offerings on CDER's Meetings, Conferences, & Workshops (Drugs) webpage. May May 5, FDA Product-Specific Guidances: Lighting the Development Pathway for Generic Drugs May 6, Meeting of the Arthritis Advisory Committee May 7, Common Labeling Deficiencies and Tips for Generic Drug Applications May 7, FDA-ASCO Hematology and Oncology Fellows Day Workshop May 11-12, Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement May 14, FDA and Health Canada Regional ICH Consultation May 18-19, Potential Medication Error Risks With Investigational Drug Container Labels Public Meeting May 27, Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement June Jun. 7-8, Morphine Milligram Equivalents: Current Applications and Knowledge Gaps, Research Opportunities, and Future Directions Jun 9, The Nonprescription Drug Facts Label in a Changing Consumer Marketplace 2021 Jun 9, Model Informed Drug Development Approaches for Immunogenicity Assessments Jun. 22, FDA-Arthritis Foundation Osteoarthritis Drug Development Workshop: Assessment of Long-term Benefit Jun. 23, FY 2021 Generic Drug Science and Research Initiatives Public Workshop July Jul. 21, Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics VI (GREAT VI) Workshop on Eosinophilic Gastrointestinal Disorders Beyond EoE Jul 22, Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics VI (GREAT VI) Workshop on Celiac Disease Recent SBIA Recordings Posted Drug Master File (DMF) and Drug Substance Question and Answer Webinar following March 3-4, 2021 Workshop The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research  provides guidance, education and updates for regulated industry. Subscribe to CDER SBIA Email Updates Register for Upcoming Training View 2021 Recordings on YouTube Follow on LinkedIn Follow on Twitter This is an automated message delivery system. Replying to this message will not reach the CDER SBIA staff. If you have comments or questions, contact us at CDERSBIA@fda.hhs.gov or 1-866-405-5367 or (301) 796-6707.  SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA